PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2882

  1. 4,296 Posts.
    lightbulb Created with Sketch. 6816
    Whitta - interesting, yeah I kinda suspected that...

    PB - Dang, know the feeling...if I have a spare $X per month I do my best to weigh it up as to where it should go, PAR usually wins.

    New guys, heck, even old guys - Be careful of higher allocations to one entity, it increases risk.

    Oops, I wasn't supposed to answer that right PB?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.